News archive search
Search the Newsreel
Search stored headlines and summaries, then narrow the results by company, country, sector, industry, source or date.
- Showing
- 325–360
- Matches
- 5705
- Sources here
- 21
- Companies here
- 31
Search results
Stored financial headlines
Active search
5705 matching headlines
Ticker or company: ENCMain company stories
Search results
Matching headlines
External headlines link to their original source. Market context comes from stored weekly company data, not from an opinion about the article.
Cadence Design Systems, Inc. (CDNS) Earnings, Actual EPS, EPS Estimates & Results
Cadence Design Systems (CDNS) announced its Q2 2026 earnings, reporting an actual EPS of $2.11, surpassing the estimated $2.05 by 2.75%. The company also reported revenues of $1.58 billion, a 24.23% increase year-over-year, beating estimates by 0.48%. CDNS provided guidance for Q3 2026 and …
CDNS
main company
Sharemaestro market context
Trend signal active
52 weeks -7.1%
Gilead Sciences Inc. stock underperforms Tuesday when compared to competitors despite daily gains
Gilead Sciences Inc. (GILD) stock saw a daily gain of 3.25% on Tuesday, closing at $143.44. Despite this increase, the stock underperformed compared to broader market indices, with the S&P 500 Index (SPX) and Dow Jones Industrial Average (DJIA) also experiencing declines. This marked …
GILD
main company
Sharemaestro market context
Price above Trend Line
52 weeks +23.7%
Legence Corp. Announces Appointment of Robert Crisci as Class II Director and Member of Audit Committee and Nomination and Corporate Governance Committee, Effective August 18, 2026
Legence Corp. has appointed Robert Crisci as a Class II director to its Board, effective August 18, 2026, increasing the Board's size from six to seven directors. Crisci will also serve on the Audit Committee and Nomination and Corporate Governance Committee. He brings extensive …
LGN
main company
Sharemaestro market context
Price below Trend Line
49 weeks +117.6% · Next-week setup positive 63.2%
Benchmark Electronics Drops 8.5% Amid Sector-Wide Selling
Benchmark Electronics, Inc. (BHE) experienced an 8.5% drop on Tuesday, closing at $77.05, as the electronic component manufacturing sector faced a broad selloff. This decline was mirrored across several peers, with no apparent company-specific news driving Benchmark's losses, suggesting broader industry concerns rather than …
BHE
main company
Sharemaestro market context
Trend signal active
52 weeks +103.3%
INTU or CDNS: Which Is the Better Value Stock Right Now?
Investors interested in Computer - Software stocks are likely familiar with Intuit (INTU) and Cadence Design Systems (CDNS). But which of these two stocks presents investors with the better value opportunity right now? Let's take a closer look. Everyone has their own methods for …
Sharemaestro market context Trend signal active 52 weeks -14.3%Tencent Music (TME) Q2 2026 Earnings Call Transcript
Image source: The Motley Fool. DATE Tuesday, Aug. 11, 2026 at 7 a.m. ET CALL PARTICIPANTS Executive Chairman - Kar Shun Pang Chief Executive Officer - Ross Liang Chief Financial Officer - Min Hu Full Conference Call Transcript Millicent T.: [Audio Gap] The earnings …
Sharemaestro market context Price below Trend Line 52 weeks -70.8% · Next-week setup negative 11.7%Twist Bioscience (NASDAQ: TWST) insider plans multimillion-dollar stock sale
An officer at Twist Bioscience (TWST), Patrick Finn, has filed a Rule 144 notice to sell up to 78,355 shares of common stock through Fidelity Brokerage Services LLC, valued at approximately $9.5 million. These shares were primarily acquired through restricted stock vesting and a …
TWST
main company
Sharemaestro market context
Trend signal active
52 weeks +314.7%
Harvard Bioscience (HBIO) Q2 2026 Earnings Call Transcript
Harvard Bioscience (HBIO) reported an 11% revenue growth in Q2 2026, driven by strong demand from CRO customers and new product platforms, leading to a raised full-year revenue guidance to 3-5%. Despite top-line success, a product and geographic mix shift towards lower-margin segments, including …
HBIO
main company
Sharemaestro market context
Trend signal active
52 weeks +36.1% · Next-week setup negative 37.0%
Could Legence (LGN) Be a Major Winner From the AI Data Center Construction Boom?
Baron Capital, an investment management company, released its Q2 2026 investor letter for the "Baron Small Cap Fund." Baron Small Cap Fund gained 12.57% (Institutional Shares) in the second quarter, trailing the Russell 2000 Growth Index's 25.71% return. A copy of the letter can …
LGN
main company
Sharemaestro market context
Price below Trend Line
49 weeks +117.6% · Next-week setup positive 63.2%
HURA: All proposals passed, including director elections and share issuance, with no stockholder questions
TuHURA Biosciences, Inc. (HURA) held its AGM 2026 where all proposals were passed, including director elections, share issuance, executive compensation, and auditor ratification. Stockholders supported the board's recommendation for a three-year frequency for compensation votes, and no questions were raised during the meeting. This …
HURA
main company
Sharemaestro market context
Trend signal active
52 weeks -24.0% · Next-week setup negative 40.8%
Anixa Biosciences to Present at the H.C. Wainwright 28th Annual Global Investment Conference
Anixa Biosciences announced that its management, led by Chairman and CEO Dr. Amit Kumar, will present at the H.C. Wainwright 28th Annual Global Investment Conference. The presentation will highlight progress in their ovarian cancer CAR-T therapy, lira-cel, which has advanced to its highest dose …
ANIX
main company
Sharemaestro market context
Trend signal active
52 weeks +3.9% · Next-week setup negative 42.4%
Anixa to present cancer data: longest survival is about 28 months
Anixa Biosciences will present clinical progress on its breast cancer vaccine and ovarian cancer CAR-T therapy, lira-cel, at the H.C. Wainwright 28th Annual Global Investment Conference. The breast cancer vaccine completed a Phase 1 trial with 74% immune response, and preparations for Phase 2 …
ANIX
main company
Sharemaestro market context
Trend signal active
52 weeks +3.9% · Next-week setup negative 42.4%
Did Strong Q2 Earnings and Completed Buybacks Just Shift Harmony Biosciences' (HRMY) Investment Narrative?
Harmony Biosciences (HRMY) reported strong Q2 2026 earnings, with net income of US$75.43 million and diluted EPS of US$1.28, and completed a US$50 million share repurchase program. While these results reinforce the company's profitability, the core investment narrative remains largely unchanged, with a continued …
HRMY
main company
Sharemaestro market context
Trend signal active
52 weeks +0.7% · Next-week setup negative 42.4%
IDEAYA Biosciences (IDYA) Reports Second Quarter Results, Is The Valuation Still Justified?
IDEAYA Biosciences (IDYA) recently reported Q2 2026 results with $8.86 million in revenue and a net loss of $112.45 million, leading investors to re-evaluate the stock despite a strong 12-month performance. The company's current Price-to-Sales (P/S) ratio of 15.1x is considered expensive compared to …
IDYA
main company
Sharemaestro market context
Trend signal active
52 weeks +44.5%
Pulse Biosciences (PLSE) Grants Equity Awards to New Hires Amid High Price-to-Sales Valuation
Pulse Biosciences (PLSE) has granted equity awards to five new hires, totaling options for 16,950 shares, to attract talent crucial for advancing its medical device technologies. The company exhibits an extremely high Price-to-Sales ratio of 2755.9x, indicating strong market expectations despite its unprofitable and …
PLSE
main company
Sharemaestro market context
Trend signal active
52 weeks +161.2%